April L. Risinger

2.3k total citations
78 papers, 1.8k citations indexed

About

April L. Risinger is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, April L. Risinger has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 30 papers in Oncology and 30 papers in Cell Biology. Recurrent topics in April L. Risinger's work include Microtubule and mitosis dynamics (27 papers), Cancer Treatment and Pharmacology (21 papers) and Phytochemical Studies and Bioactivities (17 papers). April L. Risinger is often cited by papers focused on Microtubule and mitosis dynamics (27 papers), Cancer Treatment and Pharmacology (21 papers) and Phytochemical Studies and Bioactivities (17 papers). April L. Risinger collaborates with scholars based in United States, Egypt and Saudi Arabia. April L. Risinger's co-authors include Susan L. Mooberry, Francis J. Giles, Nicholas F. Dybdal‐Hargreaves, Lin Du, Jiangnan Peng, Chris A. Kaiser, Robert H. Cichewicz, Jing Li, Evelyn M. Jackson and Gregory L. Helms and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

April L. Risinger

72 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
April L. Risinger United States 25 1.1k 515 491 413 244 78 1.8k
Manu Lopus India 24 915 0.9× 309 0.6× 516 1.1× 351 0.8× 203 0.8× 65 1.8k
Siro Simizu Japan 32 2.0k 1.9× 502 1.0× 407 0.8× 575 1.4× 180 0.7× 117 2.8k
Anindya Goswami India 25 1.2k 1.2× 272 0.5× 365 0.7× 277 0.7× 132 0.5× 83 1.9k
Lucı́lia Saraiva Portugal 26 1.2k 1.2× 390 0.8× 580 1.2× 166 0.4× 155 0.6× 109 2.1k
Alexandra Hamacher Germany 32 1.4k 1.3× 563 1.1× 526 1.1× 105 0.3× 347 1.4× 63 2.3k
Michael Brands Germany 20 1.1k 1.1× 601 1.2× 360 0.7× 201 0.5× 353 1.4× 46 2.1k
Petra Janning Germany 28 1.4k 1.3× 550 1.1× 297 0.6× 182 0.4× 366 1.5× 85 2.3k
Frank Totzke Germany 30 1.2k 1.1× 1.0k 2.0× 352 0.7× 248 0.6× 598 2.5× 79 2.6k
Gyoonhee Han South Korea 30 1.5k 1.4× 886 1.7× 474 1.0× 95 0.2× 236 1.0× 123 2.8k
Linjiang Tong China 30 1.5k 1.4× 689 1.3× 604 1.2× 108 0.3× 189 0.8× 99 2.3k

Countries citing papers authored by April L. Risinger

Since Specialization
Citations

This map shows the geographic impact of April L. Risinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April L. Risinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April L. Risinger more than expected).

Fields of papers citing papers by April L. Risinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April L. Risinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April L. Risinger. The network helps show where April L. Risinger may publish in the future.

Co-authorship network of co-authors of April L. Risinger

This figure shows the co-authorship network connecting the top 25 collaborators of April L. Risinger. A scholar is included among the top collaborators of April L. Risinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April L. Risinger. April L. Risinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Risinger, April L., et al.. (2025). RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma. Molecular Cancer Therapeutics. 24(8). 1129–1144.
2.
Youssef, Diaa T. A., et al.. (2025). Latrunculin U: a potent actin-disrupter from the Red Sea marine sponge Negombata magnifica. Natural Product Research. 1–9.
3.
4.
Crews, Phillip, et al.. (2022). In Vivo Evaluation of (−)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site. Molecules. 27(13). 4244–4244. 4 indexed citations
5.
Crews, Phillip, et al.. (2022). Re-evaluation of the Fijianolide/Laulimalide Chemotype Suggests an Alternate Mechanism of Action for C-15/C-20 Analogs. ACS Omega. 7(10). 8824–8832. 3 indexed citations
6.
Robles, Andrew J., Wentao Dai, Saikat Haldar, et al.. (2021). Altertoxin II, a Highly Effective and Specific Compound against Ewing Sarcoma. Cancers. 13(24). 6176–6176. 4 indexed citations
7.
Cai, Shengxin, April L. Risinger, Huiyun Liang, et al.. (2020). CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells. Journal of Natural Products. 83(10). 3080–3092. 12 indexed citations
8.
Cai, Shengxin, Chase M. Carver, Douglas R. Powell, et al.. (2020). Triple-Negative Breast Cancer Cells Exhibit Differential Sensitivity to Cardenolides from Calotropis gigantea. Journal of Natural Products. 83(7). 2269–2280. 21 indexed citations
9.
Balaguer, Francisco de Asís, Tobias Mühlethaler, Juan Estévez‐Gallego, et al.. (2019). Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands. International Journal of Molecular Sciences. 20(6). 1392–1392. 23 indexed citations
10.
Gupta, Harshita B., et al.. (2019). Tumor-intrinsic PD-L1 reduces actin cytoskeleton polymerization to promote mTORC1 signals driving tumor stemness. The Journal of Immunology. 202(1_Supplement). 137.8–137.8. 1 indexed citations
11.
Gentile, Taylor A., Nicholas F. Dybdal‐Hargreaves, April L. Risinger, et al.. (2018). Sterically induced conformational restriction: Discovery and preclinical evaluation of novel pyrrolo[3,2-d]pyrimidines as microtubule targeting agents. Bioorganic & Medicinal Chemistry. 26(20). 5470–5478. 5 indexed citations
12.
13.
Rohena, C.C., April L. Risinger, James A. Sikorski, et al.. (2015). Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design. Molecular Pharmacology. 89(2). 287–296. 7 indexed citations
14.
Youssef, Diaa T. A., Lamiaa A. Shaala, Gamal A. Mohamed, et al.. (2014). 2,3-Seco-2,3-dioxo-lyngbyatoxin A from a Red Sea strain of the marine cyanobacterium Moorea producens. Natural Product Research. 29(8). 703–709. 14 indexed citations
15.
Risinger, April L., et al.. (2014). The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation. Molecular Cancer. 13(1). 41–41. 34 indexed citations
16.
Peng, Jiangnan, et al.. (2013). Structure–Activity Relationships of Retro-dihydrochalcones Isolated from Tacca sp.. Journal of Natural Products. 76(12). 2189–2194. 11 indexed citations
17.
Risinger, April L., et al.. (2010). ELR510444, A Novel Microtubule Disruptor with Multiple Mechanisms of Action. Journal of Pharmacology and Experimental Therapeutics. 336(3). 652–660. 31 indexed citations
18.
Risinger, April L., Evelyn M. Jackson, Lisa Polin, et al.. (2008). The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms. Cancer Research. 68(21). 8881–8888. 111 indexed citations
19.
Risinger, April L. & Chris A. Kaiser. (2008). Different Ubiquitin Signals Act at the Golgi and Plasma Membrane to Direct GAP1 Trafficking. Molecular Biology of the Cell. 19(7). 2962–2972. 44 indexed citations
20.
Jessen, Walter J., et al.. (2004). Mapping chromatin structure in vivo using DNA methyltransferases. Methods. 33(1). 68–80. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manu Lopus Breakdown of academic impact, for papers by Siro Simizu Breakdown of academic impact, for papers by Anindya Goswami Breakdown of academic impact, for papers by Lucı́lia Saraiva Breakdown of academic impact, for papers by Alexandra Hamacher Breakdown of academic impact, for papers by Michael Brands Breakdown of academic impact, for papers by Petra Janning Breakdown of academic impact, for papers by Frank Totzke Breakdown of academic impact, for papers by Gyoonhee Han Breakdown of academic impact, for papers by Linjiang Tong
Rankless by CCL
2026